Sign in

CIK 0001590750 · Large accelerated filer

Viridian Therapeutics, Inc.\DE

Sign in to watch
Ticker
VRDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471187261
Phone
617.272.4600
Business address
221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
Former names
MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$348,194
in 1 filing

Net −$348,194. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tousignant Jennifer −$348K Chief Legal Officer sold 100% of stake

Reading 15 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-10-27 Fairmount Funds Management LLC Director Other acquisition +438,502 438,502
2020-10-27 Fairmount Funds Management LLC Director Other acquisition · Series A Non-Voting Convertible Preferred Stock +16,505 16,505
2020-10-27 Fairmount Funds Management LLC Director Other acquisition · Series A Non-Voting Convertible Preferred Stock +82,349 82,349
2020-09-14 Rauch Lee M. President & CEO Grant or award · Stock Option (right to buy) +900,000 900,000
2020-09-13 Rauch Lee M. President & CEO Grant or award · Stock Option (right to buy) +900,000 900,000
2020-05-21 Hatfield Jeffrey S. Director Grant or award · Stock Option (right to buy) +24,000 24,000
2020-05-21 TURNER JOSEPH L Director Grant or award · Stock Option (right to buy) +24,000 24,000
2020-05-21 Morris Arlene Director Grant or award · Stock Option (right to buy) +24,000 24,000
2020-05-21 KOCH KEVIN Director Grant or award · Stock Option (right to buy) +24,000 24,000
2020-05-21 Hughes Thomas E. Director Grant or award · Stock Option (right to buy) +24,000 24,000
2020-05-21 Bowden Christopher Director Grant or award · Stock Option (right to buy) +24,000 24,000
2020-03-13 Leverone Jason A. CFO, Treasurer & Secretary Option exercise +11,249 $0.57 $6K 48,829
2020-03-13 Leverone Jason A. CFO, Treasurer & Secretary Option exercise · Stock Option (right to buy) −11,249 0
2020-02-12 Escolar Diana Chief Medical Officer Grant or award · Stock Option (right to buy) +270,000 270,000
2020-02-12 Leverone Jason A. CFO, Treasurer & Secretary Grant or award · Stock Option (right to buy) +185,000 185,000
2020-02-12 Marshall William Stuart President & CEO Grant or award · Stock Option (right to buy) +464,000 464,000
2019-08-23 Leverone Jason A. CFO, Treasurer & Secretary Option exercise +3,093 $0.57 $2K 36,330
2019-08-23 Leverone Jason A. CFO, Treasurer & Secretary Option exercise · Stock Option (right to buy) −3,093 0
2019-06-19 TURNER JOSEPH L Director Grant or award · Stock Option (right to buy) +12,000 12,000
2019-06-19 Morris Arlene Director Grant or award · Stock Option (right to buy) +12,000 12,000

Page 11 of 16 · 309 trades